Chapter 13 Mitogen-activated protein kinases and stress

Cell and Molecular Response to Stress

Volumn 2, Issue C, 2001, Pages 175-193

  Hoeflich, Klaus P ^a   Woodgett, James R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0242573621     PISSN: 15681254     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1568-1254(01)80015-2     Document Type: Article

References (117)

1. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., Valladares A., Perez L., Klein R., and Nebreda A.R. Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell. 6 (2000) 109-116
2. Allen M., Svensson L., Roach M., Hambor J., McNeish J., and Gabel C.A. Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191 (2000) 859-870
3. Baker S.J., and Reddy E.P. Modulation of life and death by the TNF receptor superfamily. Oncogene 17 (1998) 3261-3270
4. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., and Evans R.M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell. 4 (1999) 585-595
5. Behrens A., Jochum W., Sibilia M., and Wagner E.F. Oncogenic tranformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19 (2000) 2657-2663
6. Behrens A., Sibilia M., and Wagner E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21 (1999) 326-329
7. Pt 2. Bishop A.L., and Hall A. Rho GTPases and their effector proteins. Biochem. J. 348 (2000) 241-255
8. Borsch-Haubold A.G., Pasquet S., and Watson S.P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J. Biol. Chem. 273 (1998) 28766-28772
9. Burbelo P.D., Drechsel D., and Hall A. A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J. Biol. Chem. 270 (1995) 29071-29074
10. Canagarajah B.J., Khokhlatchev A., Cobb M.H., and Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90 (1997) 859-869
11. Cao Z., Xiong J., Takeuchi M., Kurama T., and Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature 383 (1996) 443-446
12. Chow C.W., Rincon M., Cavanagh J., Dickens M., and Davis R.J. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 278 (1997) 1638-1641
13. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell. Biol. 7 (1997) 353-361
14. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T., and Gutkind J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81 (1995) 1137-1146
15. Courchesne W.E., Kunisawa R., and Thorner J. A putative protein kinase overcomes pheromone-induced arrest of cell cycling in S. cerevisiae. Cell 58 (1989) 1107-1119
16. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364 (1995) 229-233
17. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., and Davis R.J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms [published erratum appears in Science 1995 Jul 7; 269 (5220): 17]. Science 267 (1995) 682-685
18. Dickens M., Rogers J.S., Cavanagh J., Raitano A., Xia Z., Halpern J.R., Greenberg M.E., Sawyers C.L., and Davis R.J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277 (1997) 693-696
19. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., and Flavell R.A. Defective T cell differentiation in the absence of Jnk1. Science 282 (1998) 2092-2095
20. Dungy L.J., Siddiqi T.A., and Khan S. C-jun and jun-B oncogene expression during placental development. Am. J. Obstet. Gynecol. 165 (1991) 1853-1856
21. Elion E.A., Grisafi P.L., and Fink G.R. FUS3 encodes a cdc2+/CDC28-related kinase required for the transition from mitosis into conjugation. Cell 60 (1990) 649-664
22. Engel M.E., McDonnell M.A., Law B.K., and Moses H.L. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J. Biol. Chem. 274 (1999) 37413-37420
23. Eyers P.A., Craxton M., Morrice N., Cohen P., and Goedert M. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. Chem. Biol. 5 (1998) 321-328
24. Fanger G.R., Johnson N.L., and Johnson G.L. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. Embo J. 16 (1997) 4961-4972
25. Fuchs S.Y., Adler V., Pincus M.R., and Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA 95 (1998) 10541-10546
26. Ganiatsas S., Kwee L., Fujiwara Y., Perkins A., Ikeda T., Labow M.A., and Zon L.I. SEK1 deficiency reveals mitogen-activated protein kinase cascade cross-regulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. USA 95 (1998) 6881-6886
27. Glise B., Bourbon H., and Noselli S. hemipterous encodes a novel Drosophila MAP kinase kinase, required for epithelial cell sheet movement. Cell 83 (1995) 451-461
28. Gnarra J.R., Ward J.M., Porter F.D., Wagner J.R., Devor D.E., Grinberg A., Emmert-Buck M.R., Westphal H., Klausner R.D., and Linehan W.M. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl. Acad. Sci. USA 94 (1997) 9102-9107
29. Guillemot F., Nagy A., Auerbach A., Rossant J., and Joyner A.L. Essential role of Mash-2 in extraembryonic development. Nature 371 (1994) 333-336
30. Gum R.J., McLaughlin M.M., Kumar S., Wang Z., Bower M.J., Lee J.C., Adams J.L., Livi G.P., Goldsmith E.J., and Young P.R. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J. Biol. Chem. 273 (1998) 15605-15610
31. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., and Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. Embo J. 15 (1996) 2760-2770
32. Gupta S., Campbell D., Derijard B., and Davis R.J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267 (1995) 389-393
33. Hall-Jackson C.A., Goedert M., Hedge P., and Cohen P. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 18 (1999) 2047-2054
34. Han J., Jiang Y., Li Z., Kravchenko V.V., and Ulevitch R.J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386 (1997) 296-299
35. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
36. Han Z.S., Enslen H., Hu X., Meng X., Wu I.H., Barrett T., Davis R.J., and Ip Y.T. A conserved p38 mitogen-activated protein kinase pathway regulates Drosophila immunity gene expression. Mol. Cell. Biol. 18 (1998) 3527-3539
37. Hatai T., Matsuzawa A., Inoshita S., Mochida Y., Kuroda T., Sakamaki K., Kuida K., Yonehara S., Ichijo H., and Takeda K. Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J. Biol. Chem. 275 (2000) 26576-26581
38. Herskowitz I. MAP kinase pathways in yeast: for mating and more. Cell 80 (1995) 187-197
39. Hibi M., Lin A., Smeal T., Minden A., and Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7 (1993) 2135-2148
40. Hilberg F., Aguzzi A., Howells N., and Wagner E.F. c-jun is essential for normal mouse development and hepatogenesis. Nature 365 (1993) 179-181
41. Hoeflich K.P., Yeh W.C., Yao Z., Mak T.W., and Woodgett J.R. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 18 (1999) 5814-5820
42. Hsu H., Xiong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κ B activation. Cell 81 (1995) 495-504
43. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 (1997) 90-94
44. Ihle J.N. The challenges of translating knockout phenotypes into gene function. Cell 102 (2000) 131-134
45. Iordanov M., Bender K., Ade T., Schmid W., Sachsenmaier C., Engel K., Gaestel M., Rahmsdorf H.J., and Herrlich P. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. Embo J. 16 (1997) 1009-1022
46. Johnson R.S., van Lingen B., Papaioannou V.E., and Spiegelman B.M. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7 (1993) 1309-1317
47. Kallunki T., Deng T., Hibi M., and Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87 (1996) 929-939
48. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr. Opin. Cell Biol. 12 (2000) 186-192
49. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., and Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22 (1999) 667-676
50. Kyriakis J.M. Signaling by the germinal center kinase family of protein kinases. J. Biol. Chem. 274 (1999) 5259-5262
51. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160
52. Lali F.V., Hunt A.E., Turner S.J., and Foxwell B.M. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinsse activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J. Biol. Chem. 275 (2000) 7395-7402
53. Lee F.S., Hagler J., Chen Z.J., and Maniatis T. Activation of the IκB α kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88 (1997) 213-222
54. Lin A., Minden A., Martinetto H., Claret F.X., Lange-Carter C., Mercurio F., Johnson G.L., and Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268 (1995) 286-290
55. Liu H., Nishitoh H., Ichijo H., and Kyriakis J.M. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol. Cell. Biol. 20 (2000) 2198-2208
56. Liu Z.G., Hsu H., Goeddel D.V., and Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87 (1996) 565-576
57. Luo J., Sladek R., Bader J.A., Matthyssen A., Rossant J., and Giguere V. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-β. Nature 388 (1997) 778-782
58. Madhani H.D., and Fink G.R. The riddle of MAP kinase signaling specificity. Trends Genet. 14 (1998) 151-155
59. Malinin N.L., Boldin M.P., Kovalenko A.V., and Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385 (1997) 540-544
60. Moriguchi T., Kawasaki H., Matsuda S., Gotoh Y., and Nishida E. Evidence for multiple activators for stress-activated protein kinase/c-Jun amino-terminal kinases. Existence of novel activators. J. Biol. Chem. 270 (1995) 12969-12972
61. Moriguchi T., Toyoshima F., Masuyama N., Hanafusa H., Gotoh Y., and Nishida E. A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses. Embo J. 16 (1997) 7045-7053
62. Mudgett J.S., Ding J., Guh-Siesel L., Chartrain N.A., Yang L., Gopal S., and Shen M.M. Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. USA 97 (2000) 10454-10459
63. Nagata K., Puls A., Futter C., Aspenstrom P., Schaefer E., Nakata T., Hirokawa N., and Hall A. The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin, superfamily motor KIF3. Embo J. 17 (1998) 149-158
64. Natoli G., Costanzo A., Ianni A., Templeton D.J., Woodgett J.R., Balsano C., and Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275 (1997) 200-203
65. Nebreda A.R., and Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25 (2000) 257-260
66. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., and Matsumoto K. The kinase TAK1 can activate, the NIK-I κB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature 398 (1999) 252-256
67. Nishina H., Bachmann M., Oliveira-dos-Santos A.J., Kozieradzki I., Fischer K.D., Odermatt B., Wakeham A., Shahinian A., Takimoto H., Bernstein A., Mak T.W., Woodgett J.R., Ohashi P.S., and Penninger J.M. Impaired CD28-mediated interleukin, 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 186 (1997) 941-953
68. Nishima H., Fischer K.D., Radvanyi L., Shahinian A., Hakem R., Rubie E.A., Bernstein A., Mak T.W., Woodgett J.R., and Penninger J.M. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385 (1997) 350-353
69. Nishina H., Vaz C., Billia P., Nghiem M., Sasaki T., De la Pompa J.L., Furlonger K., Paige C., Hui C., Fischer K.D., Kishimoto H., Iwatsubo T., Katada T., Woodgett J.R., and Penninger J.M. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development 126 (1999) 505-516
70. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., Miyazono K., and Ichijo H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell. 2 (1998) 389-395
71. Noguchi K., Kitanaka C., Yamana H., Kokubu A., Mochizuki T., and Kuchino Y. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase. J. Biol. Chem. 274 (1999) 32580-32587
72. Riesgo-Escovar J.R., Jenni M., Fritz A., and Hafen E. The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye. Genes Dev. 10 (1996) 2759-2768
73. Rincon M., Whitmarsh A., Yang D.D., Weiss L., Derijard B., Jayaraj P., Davis R.J., and Flavell R.A. The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes. J. Exp. Med. 188 (1998) 1817-1830
74. Rothe M., Wong S.C., Henzel W.J., and Goeddel D.V. A novel family of putative signal transducers, associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78 (1994) 681-692
75. Sabapathy K., Hu Y., Kallunki T., Schreiber M., David J.P., Jochum W., Wagner E.F., and Karin M. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9 (1999) 116-125
76. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., and Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech. Dev. 89 (1999) 115-124
77. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J. 17 (1998) 2596-2606
78. Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., and Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372 (1994) 794-798
79. Sapin V., Dolle P., Hindelang C., Kastner P., and Chambon P. Defects of the chorioallantoic plenta in mouse RXRα null fetuses. Dev. Biol. 191 (1997) 29-41
80. Schaeffer H.J., Catling A.D., Eblen S.T., Collier L.S., Krauss A., and Weber M.J. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281 (1998) 1668-1671
81. Schaeffer H.J., and Weber M.J. Mitogen-activated protein kinases: specific messager from ubiquitous messengers. Mol. Cell. Biol. 19 (1991) 2435-2444
82. Schorpp-Kistner M., Wang Z.Q., Angel P., and Wagner E.F. JunB is essential for mammalian placentation. Embo J. 18 (1999) 934-948
83. Shi C.S., and Kehrl J.H. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-κB, by the tumor necrosis factor (TNF) receptor I through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway. J. Biol. Chem. 272 (1997) 32102-32107
84. Sluss H.K., Han Z., Barrett T., Davis R.J., and Ip Y.T. A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev. 10 (1996) 2745-2758
85. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94 (1997) 9792-9796
86. Steingrimsson E., Tessarollo L., Reid S.W., Jenkins N.A., and Copeland N.G. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development 125 (1998) 4607-4616
87. Stokoe D., Campbell D.G., Nakielny S., Hidaka H., Leevers S.J., Marshall C., and Cohen P. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. Embo J. 11 (1992) 3985-3994
88. Su G.H., Hilgers W., Shekher M.C., Tang D.J., Yeo C.J., Hruban R.H., and Kern S.E. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res. 58 (1998) 2339-2342
89. Swat W., Fujikawa K., Ganiatsas S., Yang D., Xavier R.J., Harris N.L., Davidson L., Ferrini R., Davis R.J., Labow M.A., Flavell R.A., Zon L.I., and Alt F.W. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity 8 (1998) 625-634
90. Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., and Karin M. Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102 (2000) 221-231
91. Teng D.H., Perry W.L., Hogan J.K., Baumgard M., Bell R., Berry S., Davis T., Frank D., Frye C., Hattier T., Hu R., Jammulapati S., Janecki T., Leavitt A., Mitchell J.T., Pero R., Sexton D., Schroeder M., Su P.H., Swedlund B., Kyriakis J.M., Avruch J., Bartel P., Wong A.K., Tavtigian S.V., et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57 (1997) 4177-4182
92. Tibbles L.A., and Woodgett J.R. The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 55 (1999) 1230-1254
93. Tong L., Pav S., White D.M., Rogers S., Crane K.M., Cywin C.L., Brown M.L., and Pargellis C.A. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 4 (1997) 311-316
94. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., and Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288 (2000) 870-874
95. Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., and Davis R.J. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA 94 (1997) 7337-7342
96. Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., and Davis R.J. The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol. Cell. Biol. 19 (1999) 1569-1581
97. Voss A.K., Thomas T., and Gruss P. Mice lacking HSP90β fail to develop a placental labyrinth. Development 127 (2000) 1-11
98. Wang X.S., Diener K., Manthey C.L., Wang S., Rosenzweig B., Bray J., Delaney J., Cole C.N., Chan-Hui P.Y., Mantlo N., Lichenstein H.S., Zukowski M., and Yao Z. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272 (1997) 23668-23674
99. Wang X.Z., and Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science 272 (1996) 1347-1349
100. Wendling O., Chambon P., and Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc. Natl. Acad. Sci. USA 96 (1999) 547-551
101. White R.A., Hughes R.T., Adkison L.R., Bruns G., and Zon L.I. The gene encoding protein kinase SEK1 maps to mouse chromosome 11 and human chromosome 17. Genomics 34 (1996) 430-432
102. Whitmarsh A.J., Shore P., Sharrocks A.D., and Davis R.J. Integration of MAP kinase signal transduction, pathways at the serum response element. Science 269 (1995) 403-407
103. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79 (1999) 143-180
104. Wilson K.P., McCaffrey P.G., Hsiao K., Pazhanisamy S., Galullo V., Bemis G.W., Fitzgibbon M.J., Caron P.R., Murcko M.A., and Su M.S. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol. 4 (1997) 423-431
105. Wu C.W., Li A.F., Chi C.W., Huang C.L., Shen K.H., Liu W.Y., and Lin W. Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Am. J. Pathol. 156 (2000) 2007-2015
106. Wysk M., Yang D.D., Lu H.T., Flavell R.A., and Davis R.J. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96 (1999) 3763-3768
107. Xia Y., Makris C., Su B., Li E., Yang J., Nemerow G.R., and Karin M. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. USA 97 (2000) 5243-5248
108. Yang D., Tournier C., Wysk M., Lu H.T., Xu J., Davis R.J., and Flavell R.A. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA 94 (1997) 3004-3009
109. Yang D.D., Conze D., Whitmarsh A.J., Barrett T., Davis R.J., Rincon M., and Flavell R.A. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9 (1998) 575-585
110. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotocity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
111. Yang J., Boerm M., McCarty M., Bucana C., Fidler I.J., Zhuang Y., and Su B. Mekk3 is essential for early embryonic cardivascular development. Nat. Genet. 24 (2000) 309-313
112. Yao Z., Diener K., Wang X.S., Zukowski M., Matsumoto G., Zhou G., Mo R., Sasaki T., Nishina H., Hui C.C., Tan T.H., Woodgett J.P., and Penninger J.M. Activation of stress-activated protein kianse/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase. J. Biol. Chem. 272 (1997) 32378-32383
113. Yasuda J., Whitmarsh A.J., Cavanagh J., Sharma M., and Davis R.J. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell. Biol. 19 (1999) 7245-7254
114. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., and Mak T.W. Early lethality, functional NF-κB activation and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7 (1997) 715-725
115. Yuasa T., Ohno S., Kehrl J.H., and Kyriakis J.M. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kianse (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstreamt of MKK6 and p38. J. Biol. Chem. 273 (1998) 22681-22692
116. Yujiri T., Ware M., Widmann C., Oyer R., Russell D., Chan E., Zaitsu Y., Clarke P., Tyler K., Oka Y., Fanger G.R., Henson P., and Johnson G.L. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-κ B activation. Proc. Natl. Acad. Sci. USA 97 (2000) 7272-7277
117. Zanke B.W., Rubie E.A., Winnett E., Chan J., Randall S., Parsons M., Boudreau K., McInnis M., Yan M., Templeton D.J., and Woodgett J.R. Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. J. Biol. Chem. 271 (1996) 29876-29881